NCT06607185 2026-03-13A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting750 enrolled
NCT00499291 2023-05-25Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsEastern Cooperative Oncology GroupPhase NA Withdrawn
NCT01249443 2020-07-29Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionAIDS Malignancy ConsortiumPhase 1 Terminated17 enrolled
NCT00313599 2014-07-02Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsUniversity of California, San FranciscoPhase 1 Completed28 enrolled